טוען...
Low-dose DNA demethylating therapy induces reprogramming of diverse cancer-related pathways at the single-cell level
BACKGROUND: Epigenetic reprogramming using DNA demethylating drugs is a promising approach for cancer therapy, but its efficacy is highly dependent on the dosing regimen. Low-dose treatment for a prolonged period shows a remarkable therapeutic efficacy, despite its small demethylating effect. Here,...
שמור ב:
| הוצא לאור ב: | Clin Epigenetics |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7507826/ https://ncbi.nlm.nih.gov/pubmed/32958049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-020-00937-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|